Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88103003Aexternal-prioritypatent/EP0284791B1/de
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische ProduktefiledCriticalImmuno AG
Publication of JPH012586ApublicationCriticalpatent/JPH012586A/ja
Publication of JPS642586ApublicationCriticalpatent/JPS642586A/ja
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Peptides Or Proteins
(AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Preparation Of Compounds By Using Micro-Organisms
(AREA)
JP63067987A1987-03-201988-03-22Western subtype dna and rna molecule of fsme-virus, polypeptide coded by the molecule and its usage
PendingJPS642586A
(en)
Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
Fremgangsmaate til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker, og middel til dets gjennomfoering.
Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.